Angiographic and pathologic evidence of hemorrhage into the myocardium after coronary reperfusion.
Severe myocardial hemorrhage can occur as a potential adverse effect of reperfusion therapy in evolving myocardial infarction. This report describes a 83-year-old man, who showed angiographic evidence of extravasation of contrast medium from the reperfused right coronary artery into the inferoposterior left ventricular wall. At autopsy, severe hemorrhage was transmurally observed in the inferoposterior wall of the left ventricle. The finding of extravasation is a useful angiographic sign of the production of hemorrhage during coronary reperfusion therapy, and great attention should be focused to the existence of this sign to prevent further hemorrhage.
D000368:Aged; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000473:pathology; D017023:Coronary Angiography; D003326:Coronary Circulation / Q000187:drug effects; D005119:Extravasation of Diagnostic and Therapeutic Materials; D006321:Heart / Q000000981:diagnostic imaging; D006470:Hemorrhage / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects* / Q000627:therapeutic use
D014568:Urokinase-Type Plasminogen Activator